Copper-containing mesoporous bioactive glass coatings on orbital implants for improving drug delivery capacity and antibacterial activity

Biotechnology Letters

Volumn 36, Issue 5, 2014, Pages 961-968

  Ye, Juan ^a   He, Jinjing ^a   Wang, Changjun ^a   Yao, Ke ^a   Gou, Zhongru ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Antibacterial activity; Hydroxyapatite (porous); Mesoporous bioactive glass; Orbital implant; Porous hydroxyapatite; Sustained drug release

Indexed keywords

BACTERIA; BIOACTIVE GLASS; COATINGS; DRUG DELIVERY; DRUG PRODUCTS; ESCHERICHIA COLI; EVAPORATION; HYDROXYAPATITE; SOL-GELS;

ANTI-BACTERIAL ACTIVITY; MESOPOROUS BIOACTIVE GLASS; ORBITAL IMPLANTS; POROUS HYDROXYAPATITE; SUSTAINED DRUG RELEASE;

MESOPOROUS MATERIALS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LAKE VICTORIA MARBURGVIRUS; STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; COPPER; GLASS;

CHEMISTRY; DRUG DELIVERY SYSTEM; ORBIT IMPLANT; POROSITY; PROCEDURES;

ANTI-BACTERIAL AGENTS; COPPER; DRUG DELIVERY SYSTEMS; GLASS; ORBITAL IMPLANTS; POROSITY;

EID: 84898549511     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-014-1465-x     Document Type: Article

References (16)

1. Badilla J, Dolman PJ (2008) Methods of antibiotic instillation in porous orbital implants. Ophthalmic Plast Reconstr Surg 24: 287-289.
2. Chuo JY, Dolman PJ, Ng TL, Buffam FV, White VA (2009) Clinical and histopathologic review of 18 explanted porous polyethylene orbital implants. Ophthalmology 116: 349-354.
3. Custer PL, Trinkaus KM (2007) Porous implant exposure: incidence, management, and morbidity. Ophthalmic Plast Reconstr Surg 23: 1-7.
4. Dutton JJ (1991) Coralline hydroxyapatite as an ocular implant. Ophthalmology 98(3): 370-377.
5. Hu GF (1998) Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 69: 326-335.
6. Mules PH (1990) Evisceration of the globe with artificial vitreous. 1884-1895. Adv Ophthalmic Plast Reconst Surg 8: 69-72.
7. Nunery WR, Heinz GW, Bonnin JM, Martin RT, Cepela MA (1993) Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconst Surg 9(2): 96-104.
8. Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S (2008) Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4: 707-716.
9. Shields CL, Shields JA, De Potter P (1992) Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases. Arch Ophthalmol 110: 333-338.
10. Su GW, Yen MT (2004) Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconst Surg 20: 274-280.
11. Wu C, Chang J, Xiao Y (2011) Mesoporous bioactive glasses as drug delivery and bone tissue regeneration platforms. Ther Deliv 2: 1189-1198.
12. Wu C, Zhou Y, Xu M, Han P, Chen L, Chang J, Xiao Y (2013) Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. Biomaterials 34: 422-433.
13. Yan X, Huang X, Yu C, Deng H, Wang Y, Zhang Z, Qiao S, Lu G, Zhao D (2006) The in vitro bioactivity of mesoporous bioactive glasses. Biomaterials 27: 3396-3403.
14. Yoon JS, Lew H, Kim SJ, Lee SY (2008) Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases. Ophthalmology 115: 566-572.
15. Zhang X, Wyss UP, Pichora D, Goosen MFA (1994) A mechanistic study of antibiotic release from biodegradable poly(d, 1-lactide) cylinders. J Control Rel 31: 129-144.
16. Zhu Y, Wu C, Ramaswamy Y, Kockrick E, Simon P, Kaskel S, Zreiqat H (2008) Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Micropor Mesopor Mat 112: 494-503.